Latest Finance News

North Stawell Minerals Ltd reported a strong cash position with a $1 million increase in cash reserves for the December quarter, preparing for intensified exploration activities.

DMC Mining Limited moves closer to ASX re-admission as Guinea reopens its cadastral licensing system, enabling imminent exploration licenses for key projects. The company also strengthens its leadership team and secures additional financing to support upcoming operations.

Visioneering Technologies reported a mixed Q4 FY'24 with a slight revenue decline but stronger cash flow and expanding global footprint, underpinned by promising clinical trial data.

Siren Gold Limited has completed the sale of its Reefton Project for A$22 million, retaining a significant stake in the new consolidated explorer RUA Gold Inc. The company now turns its focus to advancing the Sams Creek Project with a pending mining permit and exploration plans.

EQ Resources Limited reported a record quarterly tungsten concentrate production of 33,249 mtu, driven by operational excellence at its Saloro mine and strategic acquisitions including Tungsten Metals Group Ltd. Despite challenges at Mt Carbine due to low rainfall, the company secured significant funding and is poised for growth.

IODM Limited reported a decline in cash reserves to $461,000 for the December quarter, while projecting revenue growth through new university client onboarding in the UK and North America.

IMEXHS Limited reported a robust 34% increase in FY24 revenue to $26.5 million, driven by new contracts in Colombia and Peru that boosted its Annual Recurring Revenue to $30 million. Despite a slight EBITDA shortfall due to a bad debt expense, the company highlighted operational improvements and strengthened its regional footprint.

Golden Horse Minerals Ltd posted a CAD 413,000 net cash outflow from operating activities in the December 2024 quarter, while maintaining a robust cash balance of CAD 13.37 million. The company’s cash burn reflects ongoing exploration and evaluation investments.

Mesoblast Limited is set to launch Ryoncil®, the first FDA-approved MSC therapy for pediatric steroid-refractory acute graft-versus-host disease, backed by a recent $160 million financing that strengthens its commercial and clinical development efforts.

Careteq Limited reports solid progress in integrating its Embedded Health Solutions with HMR Referrals, alongside a 14% revenue increase and improved cash flow in Q2 FY25.

PolarX Limited's latest quarterly report reveals significant extensions of high-grade copper mineralisation at its Caribou Dome Copper Project, deepening the resource to over 300 metres and enhancing prospects for underground mining.

Ecofibre Limited reports a mixed financial performance for Q2 2025, highlighting significant debt reduction efforts and strategic restructuring to return to positive cash flows.